The FDA has authorized 20 pharmaceutical and biologic drugs this year, putting it on track to exceed last year’s 21 drug approvals, said Janet Woodcock, head of the agency’s drug division. She was responding to House legislators’ concerns that tougher standards for product safety slow the approval pace and harm drug developers. Read More @ Wall Street.
FDA expects to approve at least 21 drugs this year
Previous post: Sign Up for Webinar on Test Estimation and Planning
Next post: Referral Rewards